Thus, MTDH identified in our investigation using sIUGR twins may serve as a novel target for future treatment of IUGR and may provide a basis for developing biomarkers for this disease if dysregulated MTDH could be validated in maternal serum. Here, MTDH is linked to fetal growth restriction.